J. J. Godfroid

609 total citations
24 papers, 488 citations indexed

About

J. J. Godfroid is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, J. J. Godfroid has authored 24 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in J. J. Godfroid's work include Nitric Oxide and Endothelin Effects (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Chemical Synthesis and Reactions (3 papers). J. J. Godfroid is often cited by papers focused on Nitric Oxide and Endothelin Effects (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Chemical Synthesis and Reactions (3 papers). J. J. Godfroid collaborates with scholars based in France, Belgium and United Kingdom. J. J. Godfroid's co-authors include P. Braquet, Miguel Nomen, Ana R. Rodrı́guez, Bernd W. Spur, Françoise Heymans, Georges Dive, Josette Lamotte‐Brasseur, Rosine Labbe‐Bois, Élie Michel and Aazdine Lamouri and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

J. J. Godfroid

24 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. J. Godfroid France 12 221 192 86 68 51 24 488
Tsung-Ying Shen United States 9 114 0.5× 208 1.1× 94 1.1× 65 1.0× 55 1.1× 12 542
Jean‐Jacques Godfroid France 15 298 1.3× 323 1.7× 97 1.1× 83 1.2× 69 1.4× 33 797
Henrietta Dehmlow Switzerland 15 197 0.9× 621 3.2× 122 1.4× 61 0.9× 92 1.8× 21 969
Kenji Akahane Japan 10 181 0.8× 244 1.3× 68 0.8× 59 0.9× 53 1.0× 24 555
Mayumi Shikano Japan 9 105 0.5× 136 0.7× 93 1.1× 27 0.4× 57 1.1× 33 404
Tina M. Hallis United States 11 149 0.7× 320 1.7× 69 0.8× 55 0.8× 76 1.5× 18 513
Arthur G. Romero United States 15 255 1.2× 238 1.2× 35 0.4× 94 1.4× 18 0.4× 21 638
Hans Peter Märki Switzerland 14 182 0.8× 474 2.5× 105 1.2× 82 1.2× 65 1.3× 20 734
Eiji Ohki United Kingdom 15 431 2.0× 268 1.4× 101 1.2× 28 0.4× 55 1.1× 88 743
Richard Czerniak United States 9 185 0.8× 189 1.0× 54 0.6× 19 0.3× 24 0.5× 18 529

Countries citing papers authored by J. J. Godfroid

Since Specialization
Citations

This map shows the geographic impact of J. J. Godfroid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. J. Godfroid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. J. Godfroid more than expected).

Fields of papers citing papers by J. J. Godfroid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. J. Godfroid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. J. Godfroid. The network helps show where J. J. Godfroid may publish in the future.

Co-authorship network of co-authors of J. J. Godfroid

This figure shows the co-authorship network connecting the top 25 collaborators of J. J. Godfroid. A scholar is included among the top collaborators of J. J. Godfroid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. J. Godfroid. J. J. Godfroid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodrı́guez, Ana R., et al.. (2001). Total synthesis of 12( R )-HETE, 12( S )-HETE, 2 H 2 -12( R )-HETE and LTB 4 from racemic glycidol via hydrolytic kinetic resolution. Tetrahedron. 57(1). 25–37. 31 indexed citations
2.
Martín, Marc, Nawal Serradji, Gwenaëlle Le Pavec, et al.. (2000). PMS-601, a New Platelet-Activating Factor Receptor Antagonist That Inhibits Human Immunodeficiency Virus Replication and Potentiates Zidovudine Activity in Macrophages. Antimicrobial Agents and Chemotherapy. 44(11). 3150–3154. 19 indexed citations
3.
Rodrı́guez, Ana R., et al.. (2000). Total synthesis of lipoxin A4 and lipoxin B4 from butadiene. Tetrahedron Letters. 41(6). 823–826. 15 indexed citations
5.
Rodrı́guez, Ana R., Miguel Nomen, Bernd W. Spur, & J. J. Godfroid. (1999). Selective oxidation of primary silyl ethers and its application to the synthesis of natural products. Tetrahedron Letters. 40(28). 5161–5164. 95 indexed citations
6.
Rodrı́guez, Ana R., Miguel Nomen, Bernd W. Spur, & J. J. Godfroid. (1998). A selective method for the preparation of aliphatic methyl esters in the presence of aromatic carboxylic acids. Tetrahedron Letters. 39(47). 8563–8566. 46 indexed citations
7.
Marc, Sylvie, Bruno Pfeiffer, Dominique Manéchez, et al.. (1996). Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.. Journal of Pharmacology and Experimental Therapeutics. 278(1). 82–89. 29 indexed citations
8.
Heymans, Françoise, et al.. (1992). PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.. PubMed. 1(5). 303–12. 2 indexed citations
9.
Godfroid, J. J.. (1992). Handbook of PAF and PAF Antagonists. Trends in Pharmacological Sciences. 13. 419–419. 12 indexed citations
10.
Lamouri, Aazdine, et al.. (1991). Platelet activating factor antagonists. Structure of N,N'-bis(3,4,5-trimethoxybenzoyl)-2-piperazinylmethyl 2,2-dimethylpropanoate. Acta Crystallographica Section C Crystal Structure Communications. 47(7). 1453–1457. 3 indexed citations
11.
Lamotte‐Brasseur, Josette, Françoise Heymans, Georges Dive, et al.. (1991). PAF receptor and “cache‐oreilles” effect. Simple PAF antagonists. Lipids. 26(12Part1). 1167–1171. 16 indexed citations
12.
Braquet, P., et al.. (1987). Endothelium-dependent vasorelaxation induced by Cn — Acetal plasmalogens. Prostaglandins Leukotrienes and Medicine. 26(3). 209–219. 1 indexed citations
13.
Godfroid, J. J. & P. Braquet. (1986). PAF-acether specific binding sites: 1. quantitative SAR study of PAF-acether isosteres. Trends in Pharmacological Sciences. 7. 368–373. 39 indexed citations
14.
Braquet, P. & J. J. Godfroid. (1986). PAF-acether specific binding sites: 2. Design of specific antagonists. Trends in Pharmacological Sciences. 7. 397–403. 96 indexed citations
15.
Benveniste, Jacques, et al.. (1985). Meeting on whether there is a case for platelet activating factor acether antagonists paris france june 21 1985. Prostaglandins. 30(4). 686–729. 1 indexed citations
16.
Dive, Georges, et al.. (1982). Acide cyclohexyl-4 naphtalène-1-propionique. Acta Crystallographica Section B. 38(9). 2409–2411. 7 indexed citations
17.
Heymans, Françoise, et al.. (1982). Additional techniques for the total synthesis of PAF-acether. Inflammation Research. 12(5). 709–710. 5 indexed citations
18.
Convert, Odile, Élie Michel, Françoise Heymans, & J. J. Godfroid. (1982). 1H NMR of PAF-acether: Influence of solvent on its structure. Inflammation Research. 12(5). 706–708. 3 indexed citations
19.
Morgat, J.L., et al.. (1982). Radio-labelling of 1-O-alkyl, 2-O-acetyl,sn-glycero-3-phosphorylcholine, 1-O-(9,10-di3H)-octadecyl PAF-acether. Inflammation Research. 12(5). 705–706. 1 indexed citations
20.
Labbe‐Bois, Rosine, et al.. (1975). Quantitative structure-activity relations for dicoumarol antivitamins K in the uncoupling of mitochondrial oxidative phosphorylation. Journal of Medicinal Chemistry. 18(1). 85–90. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026